InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: Jbuffett post# 128233

Friday, 06/11/2021 3:39:31 PM

Friday, June 11, 2021 3:39:31 PM

Post# of 140474
But wait! There's MORE! Let's play the Name Game!Here's a few of interest... and it happens to encompass a majority of Titan's recent hires/appointees.

Paul Cataford - LinkedIn profile lists M&A acting as both buyer and seller.

Anthony Giovinazzo - Led the Synapsis M&A

Heather Knight - from Medtronic and Covidien, led 5 acquisitions

David McNally - started a company, got it acquired!

Cary Vance - Covidien, Medtronic; negotiated Hansen's deal with Auris (which later went to JnJ)

Deepak Basra - last worked for an M&A firm; prior Covidien

Kristen Galfetti - a VP at Synapsus when it was acquired by Sunovion

Chien Huang - from Astellas, a pharma company with a crazy acquisition strategy for growth - buy everything! Bought 5 companies while Chien was there, and at least 5 more after.

Chad Zaring - Sold Mazor to Medtronic, stopped in at Titan afterward, presumably to talk about something similar?

Didn't we also have someone leave Titan to go to Medtronic? Oh yeah! Sachin Sankholkar! A little cross-pollination never hurts, huh?

You said "too many things are pointing towards MDT and lining up towards BO." Is ten considered too many? Or at least too many to be merely coincidence! Looks like the vast majority of management and BoD additions this past year have those very experiences that I am hoping get put to use by Titan!


Message in reply to:
Thanks for the info. Another person connected to MDT. Don't know if it's a coincidence or not, but too many things are pointing towards MDT and lining up towards BO.